Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.
about
Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodentsDissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on conditioned reinstatement and reinforcement: comparison between cocaine and a conventional reinforcerPotential of Glutamate-Based Drug Discovery for Next Generation AntidepressantsZinc in the Glutamatergic Theory of DepressionBipolar disorder: candidate drug targets.Involvement of NMDAR2A tyrosine phosphorylation in depression-related behaviour.Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependenceDevelopment of allosteric modulators of GPCRs for treatment of CNS disordersMolecular Insights into Metabotropic Glutamate Receptor Allosteric ModulationProof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.(-)-2-oxa-4-aminobicylco[3.1.0]hexane-4,6-dicarboxylic acid (LY379268) and 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine (MTEP) similarly attenuate stress-induced reinstatement of cocaine seeking.Therapeutic potential of metabotropic glutamate receptor modulators.Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.Emotional Impairment and Persistent Upregulation of mGlu5 Receptor following Morphine Abstinence: Implications of an mGlu5-MOPr Interaction.The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related DisordersPotent mGluR5 antagonists: pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl seriesCharacterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [¹¹C]ABP688The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.Targeting glutamatergic signaling for the development of novel therapeutics for mood disordersMetabotropic glutamate receptor subtype 5 antagonism in learning and memory.Investigational NMDA receptor modulators for depression.New perspectives on glutamate receptor antagonists as antidepressants.Innovations in CNS drug discovery: differentiating strategies to treat depression.Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunctionLeading compounds for the validation of animal models of psychopathology.Novel glutamatergic drugs for the treatment of mood disorders.Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus biasAntidepressent Effect of Two New Benzyl Derivatives from Wild Strawberry Fragaria vesca var. nubicola Lindl. ex Hook.f.Tyrosine phosphorylation of glutamate receptors by non-receptor tyrosine kinases: roles in depression-like behavior.mGlu1 receptor as a drug target for treatment of substance use disorders: time to gather stones together?Glutamate-Based Drug Discovery for Novel Antidepressants.Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics.mGluR5 in the nucleus accumbens is critical for promoting resilience to chronic stress.Selective mGluR1 antagonist EMQMCM inhibits the kainate-induced excitotoxicity in primary neuronal cultures and in the rat hippocampus.Enhancement of Short-Term Memory by Methyl-6-(Phenylethynyl)-Pyridine in the BTBR T+tf/J Mouse Model of Autism Spectrum Disorder.In vivo positron emission tomography imaging with [¹¹C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons.Aloe vera improves memory and reduces depression in mice.Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease.
P2860
Q24656590-36E2993C-42DA-4BD5-B463-1551D5D61CCDQ24658462-80D64DA7-1CD2-4FA3-B2A7-E95E8A14DA54Q26782274-E0A41175-031A-43AE-81E0-49ADA48F4128Q26786214-74BABCB4-6390-4476-9CEF-45860A583A3AQ28751133-50BD3CA5-ADEC-42D9-9FE7-A8A13DC803CBQ30478314-241FC877-DF67-431D-BF25-F822DA6BDFB6Q33566228-855E1C3F-BB69-4E1B-B4B4-7FBDDBBDD2F9Q33788180-5F2CCF85-8FAF-429A-94B6-B2BE230E1D97Q34373958-92EBFD6D-CE8E-4D04-9A4C-AE2D9CCF9FF3Q34468639-2197E2B0-19B8-4CE7-A323-BECC08BAF270Q34766451-DAC8AEEB-D76D-4B08-9C14-40B16394ED48Q35125117-523E2570-197F-4B53-AA9F-317E63C8190FQ35478617-31FEF7FC-4125-460D-9670-9B046705E26AQ35778704-945A3146-58EE-455B-919C-1FAE248A7D92Q36899381-A5FA40BD-9084-4E8D-A083-2A1E3F146541Q37137790-03C6C0BE-0069-4408-BDBC-A8D2978BBA68Q37172873-3EF0B07C-F2B7-4014-A3E7-C0193B9F1ED0Q37305562-1AA175A7-346A-44F4-961E-3624414DA447Q37347468-EA06C052-0642-4FA8-9FEE-DA3153C53E3FQ37387700-4191823B-25B7-46B4-BA60-5EE17EEFF3BBQ37481603-63120665-7B6D-4A6A-8436-E79D101D62A5Q37723772-D7D631D7-23C5-41E2-AD5A-56588C71A404Q37957965-0E2CE809-F075-4E9A-A458-8BE56A014FF6Q38007130-20DD9BA6-A833-4F2F-BBAA-C6B5DFCD58B3Q38088733-066B4160-91FA-4EC1-A110-D5B99AEF50E0Q38125568-857CCE55-2A65-47BB-98A6-87C448A72B62Q38128733-27A9F89F-174D-4804-A45F-FD618F58A71FQ38131480-BB5E3CCE-F8B7-42AC-B2F1-EDF46306B179Q38567309-918EF09A-FB91-4039-BF55-189692FF83AEQ38633073-0B97235D-D3FD-46DD-BC22-FAC08D379BC9Q38678531-F174B25B-BD75-400D-B74B-E7BD9F7C9598Q38747119-8E193BA0-3BD2-488C-BC6B-B0EE7610AD24Q38895017-17E7ECD6-F7AC-45DF-AF13-98493CEB586CQ39261780-08D91474-48BD-4E68-9649-F710CBE0ABA5Q39277473-87933561-8918-4B38-8DC8-1515F9141472Q41811282-0DDE9B4A-3DAC-4C6A-BF8F-8981F329D418Q41890463-FA32E629-02B3-412E-A8E4-4D13566EE643Q42734765-32750ED3-5A1E-40F7-BA0A-5AEC2BDAD03AQ44265990-4DA10960-7C95-4E55-A93C-07F5F1D19F36Q46428813-7F8FF7F2-1413-4B2A-AC1A-ACA109F44AB6
P2860
Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Antidepressant-like effects of ...... e mouse tail suspension tests.
@ast
Antidepressant-like effects of ...... e mouse tail suspension tests.
@en
Antidepressant-like effects of ...... e mouse tail suspension tests.
@nl
type
label
Antidepressant-like effects of ...... e mouse tail suspension tests.
@ast
Antidepressant-like effects of ...... e mouse tail suspension tests.
@en
Antidepressant-like effects of ...... e mouse tail suspension tests.
@nl
prefLabel
Antidepressant-like effects of ...... e mouse tail suspension tests.
@ast
Antidepressant-like effects of ...... e mouse tail suspension tests.
@en
Antidepressant-like effects of ...... e mouse tail suspension tests.
@nl
P50
P1476
Antidepressant-like effects of ...... he mouse tail suspension tests
@en
P304
P356
10.1016/J.EURONEURO.2006.03.002
P407
P577
2006-04-21T00:00:00Z